Vivanza Biosciences Cash Flow Annual

BSE: 530057 | NSE: - | ISIN: INE984E01035 | Sector: Biotechnology & Drugs
2.10 -0.01 (-0.47%)Updated : 14 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net 2.81-1.571.45-1.48
Net Changein Cash -0.050.030.09-0.01
Cash Taxes Paid 0.010.150.120.00
Net Income/ Starting Line -0.670.700.720.33
Changesin Working Capital -2.200.92-2.081.72
Cashfrom Operating Activities -2.502.04-0.952.47
Cash Interest Paid 0.350.410.420.41
Cashfrom Financing Activities 2.46-1.981.03-2.48
Depreciation/ Depletion 0.010.010.000.01
Other Investing Cash Flow Items Total 0.000.000.000.00
Capital Expenditures -0.01-0.040.000.00
period Type ----
Non- Cash Items 0.350.410.420.41
Financing Cash Flow Items -0.35-0.41-0.42-1.00
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -0.01-0.040.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,400.10+41.15(1.23%)
866.65+7.95(0.93%)
419.30+2.25(0.54%)
2,401.00-38.60 (-1.58%)
1,578.15-24.85 (-1.55%)